Neuronetics (STIM) has disclosed a new risk, in the Economy & Political Environment category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Geopolitical instability in the Middle East, including ongoing conflict involving Iran, is seen as a driver of heightened global market volatility that could raise Neuronetics’ operating and financing costs. Such instability, combined with inflationary pressures, may exacerbate macroeconomic uncertainty, constraining healthcare budgets and dampening demand for its products.
In addition, supply chain disruptions, transaction restrictions, and elevated raw material costs could impair Neuronetics’ ability to manufacture and deliver its systems efficiently. These pressures could compress margins, disrupt growth plans, and ultimately have a material adverse impact on its business performance and financial results.
Overall, Wall Street has a Moderate Buy consensus rating on STIM stock based on 2 Buys.
To learn more about Neuronetics’ risk factors, click here.